Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitiglinide clinical study in type 2 diabetes mellitus
ChiCTR-TRC-11001392Phase 4Completed
- Sponsor
- The 2nd Affiliated Hospital of Chongqing Medical University
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of mitiglinide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by The 2nd Affiliated Hospital of Chongqing Medical University. Primary endpoints: inflammation, cytokine and 1 more. Started Oct 2008; status: completed.
02
Drugs
mitiglinide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-TRC-11001392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001392.